Effects of Nurse-led Supportive Care Programme on Caregiver Burden and Resilience of Family Caregivers
1 other identifier
interventional
46
1 country
1
Brief Summary
Lung cancer is the leading cause of cancer-related deaths worldwide, with a mortality rate of 18%. The prognosis of lung cancer is progressive and devastating, which may cause patients to experience problems during the treatment and care process. Due to the problems experienced by lung cancer patients, their need for support increases and the care process is provided mostly in the home environment, causing family members to take on important roles as caregivers. Therefore, the resilience of family caregivers decreases and they feel burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2023
CompletedFirst Submitted
Initial submission to the registry
January 3, 2024
CompletedFirst Posted
Study publicly available on registry
January 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 29, 2024
CompletedAugust 6, 2024
August 1, 2024
6 months
January 3, 2024
August 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Zarit Burden Interview (ZBI)
The ZBI is a measure of caregiving burden developed by Zarit et al. (1980). The Turkish version of this scale has been validated by Inci and Erdem (2018). It consists of 22 items, and responses are recorded on a five-point Likert scale. The level of caregiver burden can be ascertained based on the total scale scores, which range from 0 to 88. Higher scores indicate a higher level of caregiver burden.The Cronbach's α of the Turkish version of this scale was 0.91 in Inci and Erdem (2018) validation study.
The scale was filled in the baseline (before the beginning of the nurse-led supportive care), 8th and 12th weeks.
Secondary Outcomes (1)
Connor-Davidson Resilience Scale Short Form (CDRSSF)
The scale was filled in the baseline (before the beginning of the nurse-led supportive care), 8th and 12th weeks.
Study Arms (2)
Nurse-led Supportive Care Group
EXPERIMENTALNurse-led supportive care was given to family caregivers of patients with lung cancer.
Control Group
NO INTERVENTIONThe control group received only usual care. They did not receive any intervention during the study period.
Interventions
Nurse-led supportive care programme was applied to family caregivers for eight weeks in the form of face-to-face clinic interviews. It took an average of 40 minutes to interview with family caregivers at the clinic.
Eligibility Criteria
You may qualify if:
- A family member who has been a primary caregiver for at least one year
- Literate
- Willingness to participate in the study
You may not qualify if:
- Have any communication disability
- Have any diagnosed physical or psychological disorder
- Receiving any supportive care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Bakircay University Faculty of Health Sciences
Izmir, 35560, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pinar Zorba Bahceli, PhD
Izmir Bakircay University Faculty of Health Sciences Izmir, Turkey, 35560
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 3, 2024
First Posted
January 12, 2024
Study Start
July 31, 2023
Primary Completion
January 22, 2024
Study Completion
February 29, 2024
Last Updated
August 6, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share